Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha- ras -transformed human breast cell lines
Open Access
- 1 July 2000
- journal article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 21 (7) , 1303-1312
- https://doi.org/10.1093/carcin/21.7.1303
Abstract
The effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) on cell cycle progression were examined in the human breast cell line MCF10A-Neo and a derivative line which expresses a Ha-ras oncogene (MCF10A-NeoT cells). Exposure of MCF10A-Neo cultures to TPA induced a G1 arrest that lasted ~16–24 h (IC50 ~0.5 nM). TPA-treated cultures produced a cytostatic conditioned medium. Cytostatic activity was detectable within 1 h of TPA treatment, peaked 3–7 h later and disappeared between 16 and 24 h post-treatment. However, cytostatic conditioned medium could be quickly regenerated by re-feeding previously treated cultures with new medium. Removal of latent transforming growth factor β (TGFβ) from the culture medium, supplementing the culture medium with anti-TGFβ or soluble TGFβII receptor, or pre-absorption of conditioned medium with anti-TGFβ all reduced the cytostatic effects of TPA or conditioned medium on MCF10A-Neo proliferation by ~50%. Co-treatment with the serine protease inhibitors aprotinin or plasminogen activator inhibitor-1 also suppressed the cytostatic activity of TPA ~50%. Conditioned medium isolated from TPA-treated MCF10A-Neo cultures was transiently cytostatic to MCF10A-NeoT cells. The proliferation of MCF10A-NeoT cultures, in contrast to MCF10A-Neo cells, was suppressed at least 72 h following TPA exposure. Conditioned medium isolated from TPA-treated MCF10A-NeoT cultures also suppressed MCF10A-NeoT proliferation for ~72 h, but suppressed MCF10A-Neo proliferation for II receptor. Lastly, expression of an activated Ha-ras oncogene alters both the types of cytostatic factors produced following TPA treatment and responsiveness to these factors.Keywords
This publication has 33 references indexed in Scilit:
- Protein-kinase-C? expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell cultureInternational Journal of Cancer, 1999
- Opposite effects of TPA on G1/S transition and on cell size in the low metastatic B16F1 with respect to high metastatic BL6 murine melanoma cellsCancer Letters, 1998
- The Protein Kinase C Activator, Phorbol Ester, Elicits Disparate Functional Responses in Androgen-Sensitive and Androgen-Independent Human Prostatic Cancer CellsBiochemical and Biophysical Research Communications, 1998
- The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cellsOncogene, 1998
- Deletion of specific protein kinase C subspecies in human melanoma cellsJournal of Cellular Physiology, 1996
- Biological response to phorbol ester determined by alternative G1 pathways.Proceedings of the National Academy of Sciences, 1995
- The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF‐7 breast carcinoma cellsInternational Journal of Cancer, 1994
- In Vitro Growth Patterns of Normal Human Melanocytes and Melanocytes from Different Stages of Melanoma ProgressionJournal of Immunotherapy, 1992
- Activation and proliferation signals in mouse B cells VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetateEuropean Journal of Immunology, 1986
- Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.Proceedings of the National Academy of Sciences, 1979